Huda Shalhoub
Patient Centered Outcomes Research (P-COR) Chapter Lead Bayer
Seminars
Wednesday 3rd December 2025
Walking the Talk: Strategies for Successful Drug Development Outcomes in the Era of Patient Focused Drug Development
12:00 pm
- Highlighting the importance of involving patients in the drug development process early, from the design of clinical trials to the selection of meaningful clinical outcome assessments (COAs), ensuring their perspectives and experiences are prioritised as emphasised in FDA and EMA regulatory guidelines
- Discussing how latest research methods (e.g. in-trial interviews) and technologies (e.g. electronic COAs) can enhance the collection and reporting of patient feedback, leading to higher compliance, more accurate and truly patient centered outcomes into treatment efficacy endpoints
- Emphasising the need for pharmaceutical companies to ensure their clinical programmes are fostering a culture of continuous improvement in drug development that aligns with patient priorities and needs, as early as Phase 1
